Get the Stockscreener App
2.84
2.07%
-0.06
Onconetix Inc stock is traded at $2.84, with a volume of 22,067.
It is down -2.07% in the last 24 hours and down -39.57% over the past month.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
See More
Previous Close:
$2.90
Open:
$2.85
24h Volume:
22,067
Relative Volume:
0.03
Market Cap:
$23.99M
Revenue:
-
Net Income/Loss:
$-53.12M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-15.86M
1W Performance:
-6.58%
1M Performance:
-39.57%
6M Performance:
-42.51%
1Y Performance:
+0.00%
1-Day Range:
$2.825
$2.96
1-Week Range:
$2.825
$3.1765
52-Week Range:
$2.816
$21.40
Onconetix Inc Stock (ONCO) Company Profile
Name
Onconetix Inc
Sector
Industry
Phone
513-620-4101
Address
201 E. FIFTH STREET, CINCINNATI
Onconetix Inc Stock (ONCO) Latest News
Onconetix, Inc. (NASDAQ:ONCO) Sees Large Decline in Short Interest - MarketBeat
Onconetix announces change in certifying accountant - Investing.com India
Onconetix announces change in certifying accountant By Investing.com - Investing.com South Africa
Onconetix, Inc. (NASDAQ:ONCO) Short Interest Update - MarketBeat
Onconetix announces financing through $2M private placement - TipRanks
Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C - The Bakersfield Californian
Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit - GlobeNewswire
Onconetix raises $2 million in private placement - Investing.com
Onconetix Secures Funding to Enhance Operations and Growth - TipRanks
Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit - GlobeNewswire
Onconetix Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle
What's Going On With Onconetix Shares Friday? - MSN
Investing in Onconetix Inc (ONCO) might be a great opportunity, but the stock is a bit overvalued - US Post News
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.20% - MSN
Onconetix (NASDAQ:ONCO) Stock Quotes, Forecast and News Summary - Benzinga
Onconetix shares go way up on Altos Ventures investment and stock split - Mugglehead
Allogene Therapeutics (ALLO) Stock Jumps by 5.15% - GuruFocus.com
BeyondSpring (BYSI) Stock Surges 6.83% Amid High Volume Trading - GuruFocus.com
Wall Street Today: US Stocks Rise On Soft Inflation Data As Investors Eye Further Fed Rate Cut, Chevron Corp Gains 2.46% - MENAFN.COM
Onconetix Inc (ONCO) Stock: From Low to High in 52 Weeks - The InvestChronicle
Crude Oil Rises; Onconetix Shares Spike Higher - Benzinga
Top US Gainer Onconetix Makes Retail ‘Extremely Bullish’ After VC Firm Boosts Stake - Barchart
Nasdaq Moves Lower; Fed's Preferred Inflation Gauge Falls More Than Projected - Benzinga
Wall Street today: US stocks rise on soft inflation data as investors eye further Fed rate cut, Chevron Corp gains 2.46% | Today News - Mint
Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket - MSN
China, quantum computers and new venture capital - RagingBull
Dow Surges Over 100 Points; Costco Earnings Top Views - Benzinga
China Evergrande's liquidators still in talks for stake sale in EV unit - Yahoo Finance
Novo Nordisk Just Committed More Than $1.1 Billion to Make the Next Ozempic, but Is the Stock a Buy? - Yahoo! Voices
Traders bet on second straight 50 bps Fed rate cut in November - Yahoo Finance
China cuts short-term borrowing costs - Yahoo Finance
UK clears $4 bn AI partnership between Amazon, Anthropic - Yahoo Finance
Tradeweb CEO talks AI's impact on investing: Opening Bid - Yahoo Finance
MetLife price target raised to $88 from $84 at Evercore ISI - Yahoo Finance
Fortis raises quarterly dividend by 4.2% to C$0.615 per share - Yahoo Finance
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on October 2, 2024 - Quantisnow
Why Wall Street has the 'stocks always go up' mentality - Yahoo Finance
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.20% - MSN
Regency Centers Invites You to Join Its Third Quarter 2024 Earnings Conference Call - Yahoo Finance
IDEX Corporation to Webcast Third Quarter 2024 Earnings Call - Yahoo Finance
Southwest Airlines raises third-quarter revenue forecast - Yahoo Finance
Lennar Corporation Declares Quarterly Dividends - Yahoo Finance
Micron stock pops on earnings, guidance - Yahoo Finance
Labor Smart, Inc. Announces New Distribution Partnership with Splash Beverage Group - Yahoo Finance
Raymond James Equities Analysts Increase Earnings Estimates for OceanaGold Co. (TSE:OGC) - MarketBeat
Point72 Asia Singapore Pte. Ltd. Makes New Investment in Omnicom Group Inc. (NYSE:OMC) - MarketBeat
Fred Alger Management LLC Has $44.73 Million Position in On Holding AG (NYSE:ONON) - MarketBeat
There is no way Odyssey Marine Exploration, Inc. (OMEX) can keep these numbers up - SETE News
Bank of America CFO says Fed seems to be winning inflation battle - Yahoo Finance
EONMED Sets Sights on Becoming India's Largest Telemedicine and Microlab Leader with Strategic Expansion - Lokmat Times
Short Interest in Onconetix, Inc. (NASDAQ:ONCO) Decreases By 99.2% - Defense World
Onconetix Inc Stock (ONCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):